iRadimed Corporation - Common Stock (IRMD) stock analysis
IRMD · iRadimed Corporation - Common Stock
Latest recorded price: USD 84.84
Model-estimated fair value: USD 41.88. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Devices
At $84.84, IRMD trades 102.6% above the model's base-case value of $41.88. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $32.83 in the conservative case and $52.74 in the optimistic case, with a valuation confidence score of 93/100. Fiscal 2025 figures: revenue growth 16.3%, free cash flow margin 29.0%, ROIC 65.9%. The model flags 1 risk signal for this company.